Latest Articles
Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer - HMP Global Learning Network
Trastuzumab Pamirtecan Produces Durable Responses Across HER2 Expression Levels in Advanced Endometrial Cancer HMP Global Learning Network
Published: June 17, 2026, 8:26 p.m.
PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer - Medscape Reference
PD-1 Inhibitors Improve Survival for dMMR Endometrial Cancer Medscape Reference
Published: June 17, 2026, 2:51 p.m.
Lactate metabolism and lactylation in female reproductive diseases: From metabolic rewiring to biomarkers and translational therapeutics.
Lactate is increasingly recognized not only as a metabolic end product of glycolysis but also as a signaling metabolite that links metabolic reprogramming to epigenetic and transcriptional regulation through protein …
Published: June 17, 2026, midnight
Outdoor Air Pollution Linked to Ovarian, Endometrial Cancer - Bioengineer.org
Outdoor Air Pollution Linked to Ovarian, Endometrial Cancer Bioengineer.org
Published: June 16, 2026, 7:15 p.m.
‘How I knew I had endometrial cancer’: Survivors share their stories - UT MD Anderson
‘How I knew I had endometrial cancer’: Survivors share their stories UT MD Anderson
Published: June 16, 2026, 7:05 p.m.
Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." - La Milano
Endometrial cancer, Picardo (Acto Piemonte): "Dostarlimab offers more effective treatments for more women." La Milano
Published: June 16, 2026, 5:13 a.m.
From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 - OncLive
From Ovarian to Endometrial Cancer, Experts Spotlight Standout Data From ASCO 2026 OncLive
Published: June 15, 2026, 12:06 p.m.
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer - dailynews.lk
Endometrial Cancer, Sri Lanka’s Commonest Gynaecological Cancer dailynews.lk
Published: June 14, 2026, 7:42 p.m.
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data - TipRanks
Incyte’s POD1UM-204 Endometrial Cancer Study Wraps Up, Setting the Stage for Key Retifanlimab Data TipRanks
Published: June 11, 2026, 4:35 p.m.
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer - The ASCO Post
Four-Year RUBY Data Support Curative Intent With Dostarlimab in dMMR/MSI-H Endometrial Cancer The ASCO Post
Published: June 10, 2026, 4:41 p.m.
Link copied to clipboard!